Bleomycin — Drug Intelligence | 12 EU Trials

Filter these 12 trials by condition, phase, country and more.

Open in Search →

12 Registered trials

4 Recruiting

6 Completed trials

9 Sponsors

16 Countries

Phase III

Phase II

Phase III: 4 Phase II: 6 Phase III/IV: 1 Phase IV: 1

Oversight events:

1 temporary halt across 1 trial

View oversight register →

Indications tested

Basal cell carcinoma 1 Testicular seminoma (pure) stage I 1 Rectal cancer 1

Sponsors using this IMP

Region Sjaelland 3 Merck Sharp & Dohme LLC 2 Fondazione Policlinico Universitario Agostino Gemelli IRCCS 1 IRCCS Istituto Nazionale Tumori Fondazione Pascale 1 Region Hovedstaden 1 St. Olavs Hospital HF 1 Takeda Development Center Americas Inc. 1 University College London 1 Wroclaw Medical University 1

All trials

12 total

ORGAN SPARING FOR LOCALLY ADVANCED RECTAL CANCER AFTER NEOADJUVANT TREATMENT FOLLOWED BY ELECTROCHEMOTHERAPY - LARC_ DEEP_CANCERS Pending

2024-519050-37-00 Phase II 1 country IRCCS Istituto Nazionale Tumori Fondazione Pascale
A randomized study in testicular cancer without metastasis, comparing two different types of chemotherapy used to reduce the risk of relapse Recruiting

2024-518399-29-00 Phase III 2 countries St. Olavs Hospital HF
The BLESS Trial Recruiting

2024-513360-25-00 Phase III/IV 1 country Region Sjaelland
RADAR: A randomised phase III trial with a PET response adapted design comparing ABVD +/- ISRT with A2VD +/- ISRT in patients with previousl… Recruiting

2022-500031-37-00 Phase III 7 countries University College London
Electrochemotherapy versus standard radiotherapy for the treatment of basal cell carcinoma Recruiting

2024-519066-49-01 Phase IV 1 country Region Hovedstaden
Single-center phase II study on the use of electrochemotherapy in the treatment of Paget's disease and high-grade or initially invasive prec… Ended

2024-518796-65-00 Phase II 1 country Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Effects of calcium electroporation, electrochemotherapy, and irreversible electroporation (IRE-CaCl2, ECT and IRE) on quality of life and pr… Ended

2024-512487-61-00 Phase III 1 country Wroclaw Medical University
A phase II trial of MK-3475 (pembrolizumab) in children and young adults with classical Hodgkin lymphoma Ended

2023-504821-38-00 Phase II 8 countries Merck Sharp & Dohme LLC
Neoadjuvant electrochemotherapy for colorectal cancer - a phase 2 trial Halted

2025-520755-91-00 Phase II 1 country Region Sjaelland
Phase 2 study of pembrolizumab and chemotherapy in participants with classical Hodgkin Lymphoma that has just been diagnosed Ended

2022-501615-14-00 Phase II 4 countries Merck Sharp & Dohme LLC
Phase 3 Frontline Therapy Trial in Patients With Advanced Classical Hodgkin Lymphoma Ended

2023-506419-16-00 Phase III 9 countries Takeda Development Center Americas Inc.
Blood vessel changes in regular skin cancer undergoing either electrochemotherapy or photodynamic therapy assessed with optical coherence to… Ended

2024-518228-63-01 Phase II 1 country Region Sjaelland

Showing 1–12 of 12 trials

← All drugs A–Z